NHS meningitis B vaccination scheme begins in U.K.

The British Joint Committee on Vaccination and Immunisation recommended that a meningitis B jab be added to the routine childhood vaccination schedule. But thanks to pricing negotiations, the administration of GlaxoSmithKline's ($GSK)--formerly Novartis' ($NVS)--Bexsero to babies aged two months, four months and 12-13 months began just this week. More

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.